Global Cancer Stem Cell Therapy Market Outlook 2020 Report

“Global Cancer Stem Cell Therapy Market Outlook 2020” Report Highlight:

* Introduction & Classification of Stem Cells
* Stem Cell Transplants Classification
* Cancer Stem Cell Therapy Mechanism of Action
* Global Cancer Stem Cell Market Analysis
* Global Cancer Stem Cell Clinical Pipeline by Company & Phase
* Global Cancer Stem Cell Clinical Pipeline: 32 Therapies
* Global Cancer Stem Cell Market Dynamics: Challenges & Favorable Parameters
* Global Cancer Stem Cell Market Future Outlook

Download Report Sample Weblink:

https://www.kuickresearch.com/report-Global-Cancer-Stem-Cell-Therapy-Market-Outlook-2020.php

For Report Sample Contact: neeraj@kuickresearch.com

Table of Contents

1. Introduction to Stem Cells



2. Classification of Stem Cells

2.1 Basis of Ability to Differentiate

2.2 Basis of Origin

2.3 Basis of their Source



3. Stem Cell Transplants Classification

3.1 Autologous Stem Cell Transplants

3.2 Allogeneic Stem Cell Transplants

3.3 Syngeneic Stem Cell Transplants



4. Cancer Stem Cell Therapy Mechanism of Action

4.1 Targeting Signaling Pathways

4.1.1 Hedgehog Signaling Pathway

4.1.2 Notch Signaling Pathway

4.1.3 WNT Signaling Pathway

4.2 Targeting Cell Surface Markers

4.3 Targeting miRNA Expression



5. Global Cancer Stem Cell Market Analysis

5.1 Current Market Scenario

5.2 Global Cancer Stem Cell Therapies Pipeline Overview



6. Global Cancer Stem Cell Market Dynamics

6.1 Favorable Market Parameters

6.2 Commercialization Challenges



7. Global Cancer Stem Cell Market Future Outlook



8. Global Cancer Stem Cell Clinical Pipeline by Company & Phase

8.1 Research

8.2 Preclinical

8.3 Clinical

8.4 Phase-I

8.5 Phase-I/II

8.6 Phase-II

8.7 Phase-III



9. Discontinued & No Development of Cancer Stem Cell in Clinical Pipeline by Company & Phase

9.1 Discontinued

9.2 No Development Reported



10. Competitive Landscape

10.1 Aldagen

10.2 Apceth

10.3 Benitec Biopharma

10.4 Celgene Corporation

10.5 Cellonis Biotechnologies

10.6 Caladrius Biosciences

10.7 Commence Bio

10.8 ExCellThera

10.9 Galena Biopharma

10.10 Gamida Cell

10.11 Genexine

10.12 ImmunoCellular Therapeutics

10.13 K-STEMCELL

10.14 Medipost

10.15 Mesoblast

10.16 Novartis

10.17 Nuo Therapeutics

10.18 OncoCyte Corporation

10.19 Pluristem Therapeutics

10.20 ReNeuron

10.21 Sangamo BioSciences

10.22 Takeda

10.23 Vericel Corporation

Figure 1-1: Properties of Stem Cells

Figure 1-2: Utility of Stem Cells

Figure 1-3: Benefits of Stem Cells

Figure 1-4: Limitations of Stem Cells

Figure 2-1: Type of Stem Cells on the Basis of Ability to Differentiate

Figure 2-2: Type of Stem Cells on the Basis of Origin

Figure 2-3: Types of Stem Cells on the Basis of their Source

Figure 2-4: Different Sources of Autologous Stem Cell

Figure 3-1: Different Stem Cell Transplants

Figure 4-1: Development of Resistance in Cancerous Cells against Therapeutics

Figure 4-2: Approach for Developing Cancer Stem Cells based Therapies

Figure 4-3: Targeting Different Signaling Pathways

Figure 4-4: Mechanism of Hedgehog Signaling Pathway

Figure 4-5: Mechanism of Notch Signaling Pathway

Figure 4-6: Mechanism of Wnt Signaling Pathway

Figure 4-7: Mechanism of Cell Surface Marker for Cancer Treatment

Figure 4-8: Mechanism of miRNA Targeting

Figure 5-1: Difference between Autologous & Autogenic HSCTs

Figure 5-2: Global Stem Cell Market Opportunity (US$ Billion), 2015-2020

Figure 5-3: Global Cancer Stem Cell Therapies Pipeline by Phase (%), 2016

Figure 5-4: Global Cancer Stem Cell Therapies Pipeline by Phase (Numbers), 2016

Figure 5-5: Global Cancer Stem Cell Therapies Pipeline by Phase (%), 2016

Figure 5-6: Global Cancer Stem Cell Therapies Pipeline by Phase (Numbers), 2016

Figure 6-1: Global Cancer Stem Cell Market Favorable Parameters

Figure 6-2: Global Cancer Stem Cell Market Commercialization Challenges

Figure 10-1: Benitec Biopharma - Clinical Pipeline

Figure 10-2: Celgene - Clinical Pipeline

Figure 10-3: Caladrius - Clinical Pipeline

Figure 10-4: Commence Bio - Clinical Pipeline

Figure 10-5: Galena Biopharma - Clinical Pipeline

Figure 10-6: Gamida Cell - Clinical Pipeline

Figure 10-7: Genexie - Clinical Pipeline

Figure 10-8: ImmunoCellular Therapeutics - Clinical Pipeline

Figure 10-9: Mesoblast - Clinical Pipeline

Figure 10-10: OncoCyte Corporation - Clinical Pipeline

Figure 10-11: ReNeuron - Clinical Pipeline

Figure 10-12: Sangamo BioSciences - Clinical Pipline

Figure 10-13: Takeda - Clinical Pipeline

Figure 10-14: Vericel – Clinical Pipeline



Table 2-1: Difference between Embryonic, Adult & Induced Stem Cells

Table 3-1: Comparison between Different Types of Stem Cell Transplants

Table 3-2: Few Autologous Stem Cell Therapies under Development

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
L29 - L34, First Floor
Block L,Connaught Place
New Delhi-110001
+91-11-47067990

This release was published on openPR.